Target Enzyme Mutations Confer Differential Echinocandin Susceptibilities in Candida kefyr

Epidemiology of Candida kefyr in Patients with Hematologic Malignancies

(2014) S. F. Dufresne et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin

(2013) A. Fekkar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

PyElph - a software tool for gel images analysis and phylogenetics

(2012) Ana Brânduşa Pavel et al.   BMC BIOINFORMATICS

Topological and Mutational Analysis of Saccharomyces cerevisiae Fks1

(2012) Michael E. Johnson et al.   EUKARYOTIC CELL

Candida albicansand non-Candida albicansfungemia in an institutional hospital during a decade

(2012) Laurence Parmeland et al.   MEDICAL MYCOLOGY

New Fks Hot Spot for Acquired Echinocandin Resistance inSaccharomyces cerevisiaeand Its Contribution to Intrinsic Resistance ofScedosporiumSpecies

(2011) Michael E. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current perspectives on echinocandin class drugs

(2011) David S Perlin   Future Microbiology

Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species ofCandida

(2011) Michael A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Using the T-Coffee package to build multiple sequence alignments of protein, RNA, DNA sequences and 3D structures

(2011) Jean-Francois Taly et al.   Nature Protocols

T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension

(2011) P. Di Tommaso et al.   NUCLEIC ACIDS RESEARCH

FKS2Mutations Associated with Decreased Echinocandin Susceptibility ofCandida glabratafollowing Anidulafungin Therapy

(2010) Sofia Costa-de-Oliveira et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential Aspergillus lentulus Echinocandin Susceptibilities Are Fksp Independent

(2010) J. F. Staab et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemiology of Invasive Mycoses in North America

(2010) Michael A. Pfaller et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3- -D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

(2009) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular identification and susceptibility profile in vitro of the emerging pathogen Candida kefyr

(2009) Alicia Gomez-Lopez et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Frequency of paradoxical effect with caspofungin in Candida albicans

(2009) D. A. Stevens   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins andCandidaspp.

(2009) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Correlating Echinocandin MIC and Kinetic Inhibition of fks1 Mutant Glucan Synthases for Candida albicans: Implications for Interpretive Breakpoints

(2008) G. Garcia-Effron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins

(2008) Louise A. Walker et al.   PLoS Pathogens